Heterobicyclic carboxamides as inhibitors for kinases

Details Heterobicyclic carboxamides as inhibitors for kinases Heterobicyclic carboxamides as inhibitors for kinases

2007-03-09

2011-11-15

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S269000, C544S295000, C544S319000

Reexamination Certificate

active

08058276

ABSTRACT:
The invention relates to novel organic compounds of formula (I) and their use in the treatment of the animal or human body, to pharmaceutical compositions comprising a compound of formula (I) and to the use of a compound of formula (I) for the preparation of pharmaceutical compositions for use in the treatment of protein kinase dependent diseases, especially of proliferative diseases, such as in particular tumour diseases.

REFERENCES:
patent: 2005/012298 (2005-02-01), None
patent: 2006/059234 (2006-06-01), None
Simone, Oncology: Introduction, 20th Edition, vol. 1, pp. 1004-1010, 1996.
Traxler, Protein tyrosine kinase inhibitors in cancer treatment, Exp. Opin. Ther. Patents, 7(6), pp. 571-588, 1997.
Search Report Prepared for PCT/EP07/052217 on Oct. 17, 2007 by the European Patent Office.

Affiliated with

Also associated with

Rating

Heterobicyclic carboxamides as inhibitors for kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterobicyclic carboxamides as inhibitors for kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterobicyclic carboxamides as inhibitors for kinases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4307724